We are live on ! Find out more
HAIM

Hunter Associates Investment Management Portfolio holdings

AUM $868M
1-Year Est. Return 32.25%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+32.25%
3 Year Est. Return
+76.06%
5 Year Est. Return
+90.53%
10 Year Est. Return
+362.12%
AUM
$238M
AUM Growth
+$3.39M
Cap. Flow
-$3.7M
Cap. Flow %
-1.56%
Top 10 Hldgs %
30.82%
Holding
164
New
8
Increased
30
Reduced
66
Closed
3

Top Buys

Rank Stock Value
1
WY icon
Weyerhaeuser
WY
+$1.83M
2
ENDP
Endo International plc
ENDP
+$421K
3
IRM icon
Iron Mountain
IRM
+$365K
4
NEOS
Neos Therapeutics, Inc
NEOS
+$310K
5
TRIB
Trinity Biotech
TRIB
+$301K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.45M
2
PG icon
Procter & Gamble
PG
+$1.01M
3
AMGN icon
Amgen
AMGN
+$509K
4
IBM icon
IBM
IBM
+$451K
5
TROW icon
T. Rowe Price
TROW
+$435K

Sector Composition

Rank Sector Weight
1 Healthcare 24.26%
2 Technology 21.27%
3 Industrials 14.77%
4 Consumer Staples 9.04%
5 Energy 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFL icon
101
Aflac
AFL
$60.8B
$409K 0.17%
11,300
-2,400
-18% -$85.1K
ESRX
102
DELISTED
Express Scripts Holding Company
ESRX
$406K 0.17%
6,166
-1,304
-17% -$89.7K
JBSS icon
103
John B. Sanfilippo & Son
JBSS
$975M
$395K 0.17%
5,400
-49
-0.9% -$3.23K
UL icon
104
Unilever
UL
$134B
$387K 0.16%
6,978
+934
+15% +$47.3K
MCK icon
105
McKesson
MCK
$104B
$385K 0.16%
2,600
-100
-4% -$14.6K
JPM icon
106
JPMorgan Chase
JPM
$956B
$382K 0.16%
4,351
– –
ATRO icon
107
Astronics
ATRO
$3.77B
$381K 0.16%
16,560
– –
ENDP
108
DELISTED
Endo International plc
ENDP
$378K 0.16%
+33,900
New +$421K
BA icon
109
Boeing
BA
$186B
$376K 0.16%
2,126
– –
GOOGL icon
110
Alphabet (Google) Class A
GOOGL
$4.31T
$375K 0.16%
8,840
– –
NVO
111
Novo Nordisk
NVO
$207B
$374K 0.16%
21,830
– –
NEE icon
112
NextEra Energy
NEE
$177B
$372K 0.16%
11,600
-412
-3% -$13K
DVA icon
113
DaVita
DVA
$11.6B
$370K 0.16%
5,450
– –
IRM icon
114
Iron Mountain
IRM
$36.6B
$367K 0.15%
+10,299
New +$365K
SYY icon
115
Sysco
SYY
$40.3B
$363K 0.15%
7,000
– –
RRD
116
DELISTED
RR Donnelley & Sons Co.
RRD
$362K 0.15%
29,912
– –
NEOS
117
DELISTED
Neos Therapeutics, Inc
NEOS
$360K 0.15%
+50,000
New +$310K
WU icon
118
Western Union
WU
$2.21B
$355K 0.15%
17,450
– –
NDAQ icon
119
Nasdaq
NDAQ
$53.6B
$347K 0.15%
15,000
– –
COR icon
120
Cencora
COR
$63B
$346K 0.15%
3,905
– –
WPC icon
121
W.P. Carey
WPC
$16B
$345K 0.15%
5,667
+511
+10% +$31K
NFG icon
122
National Fuel Gas
NFG
$7.74B
$337K 0.14%
5,650
– –
WEYS icon
123
Weyco Group
WEYS
$443M
$309K 0.13%
11,000
– –
SJM icon
124
J.M. Smucker
SJM
$12.7B
$307K 0.13%
2,343
+550
+31% +$74.8K
LKSD
125
DELISTED
LSC Communications, Inc.
LKSD
$304K 0.13%
12,090
– –
3 4
5
6 7

Similar funds

HP
Havemeyer Place Greenwich, Connecticut $867M AUM
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $872M AUM 50.95% 1-Year Est. Return
SA
SoftVest Advisors Abilene, Texas $872M AUM 28.76% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM

Hunter Associates Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Hunter Associates Investment Management held 164 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Hunter Associates Investment Management's Q1 2017 filing shows 8 new, 30 increased, 66 reduced and 3 closed positions. Its largest new stake was Endo International plc: 33,900 shares worth $378K. The largest sale was Pfizer, an estimated $1.45M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Hunter Associates Investment Management's largest Q1 2017 buy was Endo International plc: 33,900 shares worth $378K.
  • Hunter Associates Investment Management added most to Weyerhaeuser in Q1 2017, an estimated $1.83M increase.
  • Hunter Associates Investment Management's biggest Q1 2017 reduction was Pfizer, cutting an estimated $1.45M.
  • Hunter Associates Investment Management fully exited NextGen Healthcare, Inc. Common Stock in Q1 2017, selling an estimated $263K.
  • Hunter Associates Investment Management's ten largest holdings make up 31% of its $238M portfolio in Q1 2017.
  • Hunter Associates Investment Management opened 8 new positions and closed 3 in Q1 2017.
  • Hunter Associates Investment Management's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Hunter Associates Investment Management's 13F filing for Q1 2017, filed 10 May 2017.